Update on Pathophysiology of Premature Ejaculation: The Bases for New Pharmacological Treatments

EAU-EBU Update Series

Volumn 4, Issue 4, 2006, Pages 141-149

  Jannini, Emmanuele A ^a   Carosa, Eleonora ^a   Pepe, Mario ^b   Lombardo, Francesco ^b   Lenzi, Andrea ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ejaculation; Erectile dysfunction; Erection; Impotence; Premature ejaculation

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; CIPROFLOXACIN; CLOMIPRAMINE; DAPOXETINE; FLUOXETINE; HERBACEOUS AGENT; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AREA UNDER THE CURVE; AWARENESS; BEHAVIOR THERAPY; CLINICAL TRIAL; DRUG POTENTIATION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HUMAN; MALE; META ANALYSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREMATURE EJACULATION; PSYCHOSEXUAL DISORDER; REVIEW; SEX THERAPY; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW;

EID: 33746069032     PISSN: 18712592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eeus.2006.05.002     Document Type: Review

References (44)

1. Jannini E.A., Simonelli C., and Lenzi A. Disorders of ejaculation. J Endocrinol Invest 25 (2002) 1006-1019
2. Jannini E.A., and Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol 23 (2005) 68-75
3. Waldinger M.D., Hengeveld M.W., and Zwinderman A.H. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 151 (1994) 1377-1379
4. Jannini E.A., Lombardo F., and Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl 28 (2005) 40-45
5. Laumann E.O., Nicolosi A., Glasser D.B., Paik A., Gingell C., Moreira E., et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 17 (2005) 39-57
6. Montorsi F. Prevalence of premature ejaculation: a global and regional perspective. J Sex Med 2 (2005) 96-102
7. Corona G., Petrone L., Mannucci E., Jannini E.A., Mansani R., Magini A., et al. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol 46 (2004) 615-622
8. Jannini E.A., Simonelli C., and Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl 25 (2002) 317-323
9. Bieber I. The psychoanalytic treatment of sexual disorders. J Sex Marital Ther 1 (1974) 5-15
10. Kaplan H. The New Sex Therapy: Active Treatment of Sexual Dysfunction (1974), Brunner/Mazel, New York
11. Dunn K.M., Croft P.R., and Hackett G.I. Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health 53 (1999) 144-148
12. Masters W., and Johnson V.E. Human Sexual Inadequacy (1970), Little, Brown & Co, Boston
13. Hawton K., and Catalan J. Prognostic factors in sex therapy. Behav Res Ther 24 (1986) 377-385
14. Heiman J.R., and Meston C.M. Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 8 (1997) 148-194
15. Leiblum S.R., and Rosen R.C. Couples therapy for erectile disorders: conceptual and clinical considerations. J Sex Marital Ther 17 (1991) 147-159
16. Holstege G., Georgiadis J.R., Paans A.M., Meiners L.C., van der Graaf F.H., and Reinders A.A. Brain activation during human male ejaculation. J Neurosci 23 (2003) 9185-9193
17. Marson L., and McKenna K.E. Serotonergic neurotoxic lesions facilitate male sexual reflexes. Pharmacol Biochem Behav 47 (1994) 883-888
18. McIntosh T.K., and Barfield R.J. Brain monoaminergic control of male reproductive behavior. II. Dopamine and the post-ejaculatory refractory period. Behav Brain Res 12 (1984) 267-273
19. Heaton J.P. Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine. Neurosci Biobehav Rev 24 (2000) 561-569
20. Xin Z.C., Chung W.S., Choi Y.D., Seong D.H., Choi Y.J., and Choi H.K. Penile sensitivity in patients with primary premature ejaculation. J Urol 156 (1996) 979-981
21. Colpi G.M., Fanciullacci F., Beretta G., Negri L., and Zanollo A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 18 (1986) 583-586
22. Waldinger M.D. The neurobiological approach to premature ejaculation. J Urol 168 (2002) 2359-2367
23. St Lawrence J.S., and Madakasira S. Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatry Med 22 (1992) 77-97
24. Goodman R.E. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res 8 (1980) 53-59
25. Waldinger M.D., Zwinderman A.H., and Olivier B. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 21 (2001) 293-297
26. Waldinger M.D. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res 15 (2003) 309-313
27. Althof S.E. Evidence based assessment of rapid ejaculation. Int J Impot Res 10 (1998) S74-S76 discussion S7-9
28. Waldinger M.D., Zwinderman A.H., Schweitzer D.H., and Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16 (2004) 369-381
29. Hamilton C.L., and Cornpropst J.D. Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono- and di-desmethyl metabolites in human plasma using column-switching high-performance liquid chromatography. J Chromatogr 612 (1993) 253-261
30. Andersson K.E., Mulhall J.P., and Wyllie M.G. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int 97 (2006) 311-315
31. Berkovitch M., Keresteci A.G., and Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol 154 (1995) 1360-1361
32. Choi H.K., Jung G.W., Moon K.H., Xin Z.C., Choi Y.D., Lee W.H., et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 55 (2000) 257-261
33. Screponi E., Carosa E., Di Stasi S.M., Pepe M., Carruba G., and Jannini E.A. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58 (2001) 198-202
34. Liang C.Z., Zhang X.J., Hao Z.Y., Shi H.Q., and Wang K.X. Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. BJU Int 93 (2004) 568-570
35. Shamloul R., and el-Nashaar A. Chronic prostatitis in premature ejaculation: a cohort study in 153 men. J Sex Med 3 (2006) 150-154
36. Brown A.J. Ciprofloxacin as cure of premature ejaculation. J Sex Marital Ther 26 (2000) 351-352
37. Carani C., Isidori A.M., Granata A., Carosa E., Maggi M., Lenzi A., et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 90 (2005) 6472-6479
38. Jannini E.A., Ulisse S., and D'Armiento M. Thyroid hormone and male gonadal function. Endocr Rev 16 (1995) 443-459
39. Mancina R., Filippi S., Marini M., Morelli A., Vignozzi L., Salonia A., et al. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 11 (2005) 107-115
40. Fein R.L. Intracavernous medication for treatment of premature ejaculation. Urology 35 (1990) 301-303
41. Abdel-Hamid I.A., El Naggar E.A., and El Gilany A.H. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 13 (2001) 41-45
42. Salonia A., Maga T., Colombo R., Scattoni V., Briganti A., Cestari A., et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 168 (2002) 2486-2489
43. Chen J., Mabjeesh N.J., Matzkin H., and Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 61 (2003) 197-200
44. Dresser M.J., Desai D., Gidwani S., Seftel A.D., and Modi N.B. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res 18 (2006) 104-110